Efecto bimodal de la ciclofosfamida en la terapia antineoplásica

Autor: Matar, Pablo, Scharovsky, O. Graciela

Publikováno v: Revista Brasileira de Cancerologia; Vol. 42 No. 1 (1996): Jan./Feb./Mar.; 33-42
Revista Brasileira de Cancerologia; Vol. 42 Núm. 1 (1996): ene./feb./mar.; 33-42
Revista Brasileira de Cancerologia; v. 42 n. 1 (1996): jan./fev./mar.; 33-42
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Cyclophosphamide (Cy), one ofthe chemotherapeutic agents more frequently used in clinical oncology, was originated after the Chemical strueture of mechlorethamine was modified to obtain an anticancer agent with higher selectivity for neoplastic tissu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::0ba61526971bf90f2cce28cca165e691
https://rbc.inca.gov.br/index.php/revista/article/view/2880

Immunotherapy for liver tumors: present status and future prospects

Autor: Gidekel Manuel, Atorrasagasti Catalina, Malvicini Mariana, Aquino Jorge B, Rozados Viviana, Alaniz Laura, Matar Pablo, Silva Marcelo, Scharovsky O Graciela, Mazzolini Guillermo

Publikováno v: Journal of Biomedical Science, Vol 16, Iss 1, p 30 (2009)

Abstract Increasing evidence suggests that immune responses are involved in the control of cancer and that the immune system can be manipulated in different ways to recognize and attack tumors. Progress in immune-based strategies has opened new thera

Externí odkaz: https://doaj.org/article/5e760df508194a2fbbed5ba1947dc2ee

Chemoimmunotherapy for advanced gastrointestinal carcinomas

Autor: Malvicini, Mariana, Piccioni, Flavia, Bayo, Juan, Fiore, Esteban, Atorrasagasti, Catalina, Alaniz, Laura, Garcia, Mariana, Aquino, Jorge B., Gidekel, Manuel, Matar, Pablo, Mazzolini, Guillermo

Publikováno v: Oncoimmunology

The combination of a single low dose of cyclophosphamide (Cy) with the adenovirus-mediated gene transfer of interleukin-12 (AdIL-12) might represent a successful therapy for experimental gastrointestinal tumors. This approach has been proven to rever

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7276a6ff471376b61ca72d9eb3d8f8c3
http://europepmc.org/articles/PMC3525625

Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model

Autor: Rico, María José, Rozados, Viviana R., Mainetti, Leandro Ernesto, Zacarías Fluck, Mariano, Matar, Pablo, Scharovsky, O. Graciela

Publikováno v: RepHipUNR (UNR)
Universidad Nacional de Rosario
instacron:UNR

Aim: Experimental and clinical studies showed that the administration of cyclophosphamide (Cy) in low doses leads to an enhancement of the antitumor immune response. Our objective was to study the modulation, if any, by low dose Cy, of T regulatory (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::fa724df311b63807e18aa9f6f13a1455

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.